About Us

Innovation means both novelty and change. We focus on both, as they are essential foundations for meeting today's requirements for successful biotechnological processes.

TrophoSYS GmbH develops innovative technologies, processes and products, particularly for the male reproductive aptitude market, which make a significant contribution to improving fertility while using ejaculates gently and in a targeted manner.

Global reproductive capacity is declining, making the development of technologies that are especially safe for human health essential and a primary goal of our solutions and developments. Sustainable resource management, adherence to ethical principles, and the avoidance of genetic manipulation are paramount.

Pooling diversity, securing a competitive edge – TrophoSYS GmbH combines expert knowledge from various disciplines into a powerful whole. This allows you to benefit from in-depth experience and interdisciplinary solutions.

Our core areas at a glance:

• Research & Development: Innovative solutions at the cutting edge.

• Science: Sound expertise in chemistry and physics.

• Business: Strategic expertise in management and finance.

Initial successes have already been achieved in a very short time, demonstrating that the combination of entrepreneurial experience and scientific expertise provides the best foundation for a successful project. This, combined with a high-quality network of partners, ensures that all individual projects can be implemented quickly and to a high standard.

TrophoSYS' innovative methods enable, on the one hand, the improvement of breeding results through the separation of vital and non-vital cells in the ejaculate, and on the other hand, targeted breeding through the more efficient separation of sperm containing X and Y chromosomes.

With this method for separating vital and non-vital cells, the company is breaking new ground worldwide and is currently the only provider with this highly efficient technology. Device development has been completed, toxicity tests have already been successfully conducted, and the necessary field studies have been successfully concluded.

Our technologies are based on two main principles: firstly, the utilization of the different surface properties of the respective cell species, and secondly, the use of specially developed excipient concepts that significantly enhance the differentiation of these surface properties. The actual separation takes place in a device developed by TrophoSYS using a process that cannot negatively affect cell health or even genetically manipulate cells.

The success of the separation technology, which was designed for cattle to date, has led TrophoSYS to already be taking preparatory measures to extend the technology concept to other mammals.

The adaptation of the process for horse breeding is already very advanced, and the optimization of stallion ejaculates is possible. The company is currently conducting a final, comprehensive study and, upon successful completion, will be able to provide a kit that will enable any breeder worldwide to independently optimize samples from their own animals.

Due to recurring demand for the potential development of a solution for human applications, TrophoSYS has begun the conceptual design phase. In collaboration with a Munich cryotherapy center, a proof of concept has already been achieved, and the framework for a collaboration is currently being developed with a major international market player.

With its innovative projects, devices and processes, TrophoSYS aims not only to create an economically successful model, but also to contribute to improving the global fertility opportunities of mammals through the use of new technologies.

The company has set itself the goal of developing separation technologies with the following properties:

Consistent application by the end customer can thus increase the chances of fulfilling the desire for offspring, which on the one hand does not require any genetic manipulation and on the other hand is also highly efficient and cost-effective to implement.

TrophoSYS is thus developing urgently needed procedures that positively influence the future of fertility, are affordable for the individual, do not cause additional psychological pressure, and can be used with a clear conscience.

TrophoSYS gets the most out of your sperm, thus increasing your chances of offspring! We are convinced that we will be able to offer the methods we have developed to a broad audience in the future, for a wide variety of mammals, but also for human needs.

The European Union and the state of Thuringia support the project:

"High-efficiency methods for sex-specific germ cell separation for sustainable animal breeding and qualitative improvement of the nutritional situation."

This support makes it possible to bring about lasting positive change in the field of animal breeding. Using TrophoSYS's methods, it becomes possible to achieve more efficient results without interfering with the gene pool of the respective species, thus improving the situation from both an economic and ethical perspective: innovative and gentle at the same time.

Thanks to the many years of professional experience of the initiators and founders, TrophoSYS GmbH can draw on a broad network of competent partnerships, knowledge holders and experts who serve the goal of successfully developing future technologies and significantly influence its successful progress.

Against this background, the following partnerships are of particular importance, but represent only a small selection of the available expertise.